AnalystsEd ArceEd Arce's Stock Forecasts
AnalystsEd Arce
Analyst Ranking
Top 27%
#1210 out of 4559 analysts
Average Return
+0.66%
Win Rate
35%105 out of 301
Risk vs Reward
Poor
Good
Ed Arce's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cymabay Therapeutics IncCBAY | +481.01% | $1.79 | $10.40 | 2022-05-16 - 2023-05-15 | Buy |
Vera Therapeutics IncVERA | +416.91% | $7.57 | $39.13 | 2023-05-12 - 2024-04-22 | Buy |
Viking Therapeutics IncVKTX | +350.00% | $2.74 | $12.33 | 2017-11-10 - 2018-11-09 | Buy |
Vera Therapeutics IncVERA | +349.77% | $8.70 | $39.13 | 2023-06-08 - 2024-04-22 | Buy |
89bio IncETNB | +338.51% | $3.48 | $15.26 | 2022-07-28 - 2023-07-27 | Buy |
Ed Arce Analyst Color
Get additional color on Ed Arce's coverage of popular stocks
Ed Arce's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Galectin Therapeutics IncGALT | 8 | Buy | $11.00 | +259.48% | Reiterates | 14 days ago |
Cidara Therapeutics IncCDTX | 16 | Buy | $6.00 | +1,067.32% | Maintains | 15 days ago |
Genfit SaGNFT | 10 | Buy | $11.00 | +200.55% | Reiterates | 18 days ago |
Mirum Pharmaceuticals IncMIRM | 21 | Buy | $58.00 | +139.97% | Maintains | 21 days ago |
Iterum Therapeutics PLCITRM | 5 | Buy | $6.00 | +279.75% | Reiterates | 22 days ago |
Inventiva SaIVA | 11 | Buy | $22.00 | +566.67% | Reiterates | 22 days ago |
Unicycive Therapeutics IncUNCY | 14 | Buy | $4.50 | +291.30% | Reiterates | 22 days ago |
Akebia Therapeutics IncAKBA | 20 | Buy | $6.00 | +341.18% | Maintains | a month ago |
89bio IncETNB | 14 | Buy | $31.00 | +232.98% | Maintains | a month ago |
Zyversa Therapeutics IncZVSA | 4 | Buy | $12.00 | +1,986.96% | Reiterates | a month ago |
Acurx Pharmaceuticals IncACXP | 10 | Buy | $12.00 | +506.06% | Maintains | a month ago |
Terns Pharmaceuticals IncTERN | 7 | Hold | $5.50 | +14.11% | Reiterates | a month ago |
Madrigal Pharmaceuticals IncMDGL | 11 | Buy | $425.00 | +99.07% | Maintains | a month ago |
Travere Therapeutics IncTVTX | 14 | Buy | $17.00 | +190.60% | Maintains | a month ago |
Arcturus Therapeutics Holdings IncARCT | 17 | Buy | $60.00 | +121.73% | Reiterates | 2 months ago |
Talphera IncTLPH | 9 | Buy | $6.00 | +545.16% | Reiterates | 2 months ago |
Akero Therapeutics IncAKRO | 14 | Buy | $50.00 | +140.50% | Maintains | 2 months ago |
Aurinia Pharmaceuticals IncAUPH | 11 | Buy | $13.00 | +157.43% | Reiterates | 2 months ago |
Arbutus Biopharma CorpABUS | 13 | Buy | $5.00 | +89.39% | Maintains | 2 months ago |
Cymabay Therapeutics IncCBAY | 13 | Hold | $32.50 | +0.06% | Reiterates | 2 months ago |
Pliant Therapeutics IncPLRX | 13 | Buy | $48.00 | +280.95% | Reiterates | 2 months ago |
Vera Therapeutics IncVERA | 7 | Buy | $25.00 | -36.11% | Reiterates | 4 months ago |
Enanta Pharmaceuticals IncENTA | 6 | Buy | $28.00 | +108.33% | Maintains | 5 months ago |
Ardelyx IncARDX | 3 | Buy | $11.00 | +68.97% | Maintains | 6 months ago |
Intercept Pharmaceuticals IncICPT | 10 | Hold | $19.00 | 0.00% | Downgrades | 7 months ago |
Synlogic IncSYBX | 6 | Buy | $75.00 | +3,976.09% | Reiterates | 8 months ago |
Durect CorpDRRX | 6 | Buy | $27.00 | +3,254.04% | Maintains | 8 months ago |
Paratek Pharmaceuticals IncPRTK | 9 | Hold | $2.15 | -3.59% | Reiterates | 9 months ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Buy | $82.00 | +87.69% | Reiterates | 9 months ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $40.00 | -0.97% | Reiterates | 10 months ago |
Assembly Biosciences IncASMB | 2 | Hold | $18.00 | N/A | Maintains | a year ago |
Albireo Pharma IncALBO | 7 | Hold | $42.00 | N/A | Reiterates | a year ago |
Axcella Health IncAXLA | 4 | Hold | N/A | N/A | Downgrades | a year ago |
Mimecast LtdMIME | 1 | Buy | $69.00 | N/A | Maintains | 2 years ago |
Entasis Therapeutics Holdings IncETTX | 3 | Hold | $1.80 | N/A | Downgrades | 2 years ago |
Dicerna Pharmaceuticals IncDRNA | 6 | Hold | $38.25 | N/A | Downgrades | 2 years ago |
Metacrine IncMTCR | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Galmed Pharmaceuticals LtdGLMD | 3 | Buy | $375.00 | N/A | Maintains | 3 years ago |
Avenue Therapeutics IncATXI | 2 | Buy | $195.00 | N/A | Maintains | 4 years ago |
Trevena IncTRVN | 4 | Buy | $87.50 | N/A | Assumes | 5 years ago |
Tetraphase Pharmaceuticals IncTTPH | 2 | Buy | $7.00 | N/A | Maintains | 6 years ago |
Viking Therapeutics IncVKTX | 1 | Buy | $7.00 | N/A | Assumes | 6 years ago |
Ocera Therapeutics IncOCRX | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Collegium Pharmaceutical IncCOLL | 1 | Buy | $21.00 | N/A | Initiates Coverage On | 7 years ago |
Nabriva Therapeutics PLCNBRVF | 2 | Buy | $4,500.00 | N/A | Maintains | 7 years ago |
Atea Pharmaceuticals IncAVIR | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Medicines CoMDCO | 1 | Buy | $57.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.